Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2BC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HSPA14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1GALT1C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM53A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RBAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPEAR-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on